Discovery of additional viral reservoir reveals new target for HIV cure research
Can't see this email? View it online
   
  April 19, 2017  
  HIV/AIDS  
  The latest HIV/AIDS news from News Medical  
 Discovery of additional viral reservoir reveals new target for HIV cure researchDiscovery of additional viral reservoir reveals new target for HIV cure research
 
HIV cure research to date has focused on clearing the virus from T cells, a type of white blood cell that is an essential part of the immune system.
 
 
 Positive emotion intervention improves health in people newly diagnosed with HIVPositive emotion intervention improves health in people newly diagnosed with HIV
 
When individuals recently diagnosed with HIV were coached to practice skills to help them experience positive emotions, the result was less HIV in their blood and lower antidepressant use, reports a new Northwestern Medicine study.
 
   UTHealth participates in study to evaluate effectiveness of new injectable HIV medicationUTHealth participates in study to evaluate effectiveness of new injectable HIV medication
 
The HIV Prevention Trials Network, which includes McGovern Medical School at The University of Texas Health Science Center at Houston, has launched a study to evaluate whether a new injectable medication can work as well as an existing oral pill to safely protect against HIV among men who have sex with men (MSM) and transgender women (TGW) who have sex with men.
 
   Injection drug use linked to increase in immune activation, says researcherInjection drug use linked to increase in immune activation, says researcher
 
The use of heroin and other illicit drugs has been shown to trigger a response from the body's immune system.
 
 Bacteriophages may help combat antibiotic-resistant 'superbugs'
 
Bacteriophages may help combat antibiotic-resistant 'superbugs'Viruses that specifically kill bacteria, called bacteriophages, might one day help solve the growing problem of bacterial infections that are resistant to antibiotic treatment.
 
 
 NIH scientists identify protein complexes involved in promoting HSV infection and reactivation
 
NIH scientists identify protein complexes involved in promoting HSV infection and reactivationHerpes simplex virus (HSV) infections last a lifetime. Once a person has been infected, the virus can remain dormant (latent) for years before periodically reactivating to cause recurrent disease. This poorly understood cycle has frustrated scientists for years.